GlassScriptPhysician profile
Ruth E Sakakeeny
NPI 1710064167
$1,365.29
in general payments reported to CMS, 2019-2025
17 companies · $290 in 2025
The $290 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $51.89 · 2022: $204 · 2023: $429 · 2024: $195 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $264.17 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $180.35 | 2019-2025 | Gardasil 9, M-M-R II, Vaxelis |
| Corium, LLC | $154.65 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $124.88 | 2019-2023 | Rotarix, Bexsero |
| Sanofi Pasteur INC. | $122.64 | 2020-2025 | |
| Seqirus USA INC | $117.11 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Kaleo, INC. | $112.20 | 2019-2024 | Auvi-Q |
| Shire North American Group INC | $42.96 | 2019 | |
| Cranial Technologies, INC | $41.27 | 2024-2025 | Doc Band |
| Sobi, INC | $39.11 | 2022-2023 | |
| Alk-Abello, INC | $36.39 | 2025 | Neffy |
| Alexion Pharmaceuticals, INC. | $35.09 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $34.02 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $28.28 | 2020 | |
| Mylan Pharmaceuticals INC. | $16.24 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $15.93 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$151,665.13 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Sakakeeny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.